发明授权
US07300644B2 Targeted combination immunotherapy 有权
靶向组合免疫治疗

Targeted combination immunotherapy
摘要:
The present invention is directed to methods for treating cancer wherein more than one therapeutic agent is used, with each of the therapeutic agents having different tumor-killing capabilities, and wherein the therapeutic agents are delivered to the tumor sites using combined targeting and pre-targeting methods. The methods of the present invention achieve good tumor to non-tumor ratios of the therapeutic agents, and are effective for cancer therapy.
公开/授权文献
信息查询
0/0